The Food and Drug Administration (FDA) announced the tentative approval of two applications for nevirapine tablets manufactured by Ranbaxy Laboratories Limited, Guragon, India and Aurobindo Pharma Limited, Hyderabad, India. These are the first generic versions of Viramune Tablets manufactured by Boehringer Ingelheim. These products will now be available for consideration for purchase under the President?s Emergency Plan for AIDS Relief (PEPFAR).
For the first time, scientists have shown that humans use an immune defense process common in plants and invertebrates to battle a virus. The new finding that human cells can silence an essential part of HIV?s genetic make-up could have important implications for the treatment of people infected with the virus. Led by Kuan-Teh Jeang, M.D, Ph.D., of the National Institute of Allergy and Infectious Diseases (NIAID), part the National Institutes of Health, the researchers published their findings in this week?s issue of the journal Immunity.
Cure, not treatment, is the subject of this book. In 1991 Dr. Clark discovered the source of HIV. Once the source became clear the cure became obvious. but would it work?
Very early treatment of babies infected with HIV — before age 3 months — is associated with better outcomes than when treatment is delayed, investigators report in this week’s Journal of the American Medical Association.
Researchers at Mount Sinai School of Medicine in New York report they have found a key to controlling the HIV infection.
Originally, it seemingly appeared that anyone infected with HIV would progress to disease and die. This has long since been realized to no longer be true. We have individuals all over the world who are living 20 years or more without progression to disease and without the need for antiretroviral (ARV) medications.
Individuals living with HIV and AIDS may not only have to deal with the threat of illness but the toll of illness. All that is required to stay healthy and alive can leave an everlasting mark! I’m referring to the loss of subcutaneous fat from the face, commonly referred to as facial wasting or Lipoatrophy.
The World Health Organization (WHO) is reinstating two antiretrovirals manufactured by Cipla Ltd., India, in its list of prequalified medicines. The two medicines (which are used in the treatment of AIDS) had been delisted by WHO in May this year due to non-compliance with international standards at the contract research organizations (CROs) hired by Cipla to conduct bioequivalence tests on the products.
Around the world the use of condoms is seen as a trusted weapon in the prevention of HIV infection. However, these efforts are often hampered by religious beliefs.
The epidemic of human immunodeficiency virus infection is growing more rapidly in women than in men in almost every part of the world, according to a new report.